10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2019 | |||
Consolidated Statements of Operations | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 18, 2020) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
| Revenues: | |||
| Premiums | $ 63,122 | 8,184 | 3,558 |
| Net investment income | 1,011 | 660 | 21 |
| Total revenues | 256,776 | 194,579 | 184,786 |
| Operating costs: | |||
| Cost of products sold | 158,719 | 156,447 | 153,448 |
| Benefit costs | 52,529 | 6,594 | 2,810 |
| Goodwill impairments | 0 | 6,149 | 181 |
| Operating expenses | 33,541 | 21,368 | 18,809 |
| Total operating costs | 244,789 | 190,558 | 175,248 |
| Operating income | 11,987 | 4,021 | 9,538 |
| Interest expense | 3,035 | 2,619 | 1,062 |
| Loss on early extinguishment of debt | 79 | 0 | 0 |
| Other expense (income) | (124) | (4) | 208 |
| Income before income tax provision | 8,997 | 1,406 | 8,268 |
| Income tax provision | 2,366 | 2,002 | 1,637 |
| Income (loss) from continuing operations | 6,631 | (596) | 6,631 |
| Loss from discontinued operations, net of tax | 0 | 0 | (8) |
| Net income (loss) | 6,631 | (596) | 6,623 |
| Net (income) loss attributable to noncontrolling interests | 3 | 2 | (1) |
| Net income (loss) attributable to CVS Health | 6,634 | (594) | 6,622 |
| Basic earnings (loss) per share: | |||
| Income (loss) from continuing operations attributable to CVS Health (in dollars per share) | 5.10 | (0.57) | 6.48 |
| Loss from discontinued operations attributable to CVS Health (in dollars per share) | 0.00 | 0.00 | (0.01) |
| Net income (loss) attributable to CVS Health (in dollars per share) | 5.10 | (0.57) | 6.47 |
| Weighted average basic shares outstanding (in shares) | 1,301 | 1,044 | 1,020 |
| Diluted earnings (loss) per share: | |||
| Income (loss) from continuing operations attributable to CVS Health (in dollars per share) | 5.08 | (0.57) | 6.45 |
| Loss from discontinued operations attributable to CVS Health (in dollars per share) | 0.00 | 0.00 | (0.01) |
| Net income (loss) attributable to CVS Health (in dollars per share) | 5.08 | (0.57) | 6.44 |
| Weighted average diluted shares outstanding (in shares) | 1,305 | 1,044 | 1,024 |
| Dividends declared per share (in dollars per share) | 2.00 | 2.00 | 2.00 |
| Product and Service | |||
| Products | |||
| Revenues | 185,236 | 183,910 | 180,063 |
| Services | |||
| Revenues | 7,407 | 1,825 | 1,144 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2019 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |